CPRX - Catalyst Pharmaceuticals' (CPRX) CEO Patrick McEnany on Q1 2021 Results - Earnings Call Transcript
Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants Alicia Grande – Vice President, Chief Financial Officer and Treasurer Patrick McEnany – Chairman and Chief Executive Officer Jeffrey Del Carmen – Chief Commercial Officer Steven Miller – Chief Operating Officer and Chief Scientific Officer Brian Elsbernd – Chief Legal and Compliance Officer Conference Call Participants Charles Duncan – Cantor Fitzgerald Leszek Sulewski – Truist Presentation Operator Greetings, and welcome to the Catalyst Pharmaceuticals’ First Quarter 2021 Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Alicia Grande, Vice President, Chief Financial Officer and Treasurer. Thank you. You may begin. Alicia Grande Good morning, everyone, and thank you for joining our
For further details see:
Catalyst Pharmaceuticals' (CPRX) CEO Patrick McEnany on Q1 2021 Results - Earnings Call Transcript